Skip to main content
Fig. 1 | Journal of Cardiothoracic Surgery

Fig. 1

From: Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery – a retrospective analysis

Fig. 1

Patient inclusion flow chart. From 3.951 patients operated on in the inclusion period, 288 presented with preoperative LVEF ≤35%. Of these, 84 patients received prophylactic LS and 204 did not. After propensity score matching, 246 patients remained in the analysis with 82 patients in the LS group and 164 patients in the control group. Abbreviations: CABG: Coronary artery bypass grafting surgery, LS: Levosimendan, LVEF: Left-ventricular ejection fraction

Back to article page